Skip to main content
Clinical Trials/NL-OMON56447
NL-OMON56447
Recruiting
Not Applicable

oninvasive electrocardiographic imaging for individuals at risk for apparently idiopathic ventricular fibrillation - VIGILANCE

Medisch Universitair Ziekenhuis Maastricht0 sites550 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Idiopathic ventricular fibrillation
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
550
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must be \>\= 18
  • years old and meet one of the following criteria:\- All unexplained polymorphic
  • VT or VF survivors in whom known structural myocardial, respiratory, metabolic
  • and toxicological causes have been excluded through clinical evaluation\*,
  • with/without a genetic mutation.
  • NB. If results of a diagnostic tests show minor abnormalities but insufficient
  • for a specific diagnosis, this is no exclusion criterion.
  • \- Selected family members of these patients\*
  • \- Control subjects with structurally normal hearts with a clinical indication
  • for a cardiac CT scan, as already approved in METC protocol NL32128\.068\.11 (ABR

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:\- A known strong reaction against electrode
  • attachment or contrast agent.
  • \- Any serious medical condition, which in the opinion of the investigator, may
  • adversely affect the safety and/or effectiveness of the participant or the
  • \- Pregnancy, nursing or planning to be pregnant.
  • \- Subject has an estimated glomerular filtration rate (eGFR) of
  • \<30mL/min/1\.73m2, using the MDRD calculation.
  • \- Unability to give informed consent.
  • \- Family members of a patients with idiopathic unexplained polymorphic VT/VF ,

Outcomes

Primary Outcomes

Not specified

Similar Trials